Labvantage - Biomax Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Employees
-
33
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
8
- Investments
-
1
Labvantage - Biomax General Information
Description
Provider of software services intended for efficient decision-making and knowledge management at the intersection of life sciences, healthcare and information technologies. The company offers customizable solutions like semantic search, brain imaging and clinical integration, enabling biotech, pharma, agriculture and research institutes to drive digital transformation.
Contact Information
Website
www.labvantage-biomax.com(Operating Subsidiary)
Corporate Office
- Robert-Koch-Street 2
- 82152 Planegg
- Germany
Corporate Office
- Robert-Koch-Street 2
- 82152 Planegg
- Germany
Labvantage - Biomax Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Labvantage - Biomax Comparisons
Industry
Financing
Details
Labvantage - Biomax Competitors (12)
One of Labvantage - Biomax’s 12 competitors is Genestack, a Corporation company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genestack | Corporation | Cambridge, United Kingdom | ||||
| Clinithink | Venture Capital-Backed | Bridgend, United Kingdom | ||||
| Averbis | Corporation | Freiburg im Breisgau, Germany | ||||
| Quest Diagnostics | Corporation | Secaucus, NJ | ||||
| Genuity Science | Formerly VC-backed | Dublin, Ireland |
Labvantage - Biomax Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Labvantage - Biomax Patents
Labvantage - Biomax Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201702600-D0 | Neurological data processing | Inactive | 17-Feb-2017 | ||
| DE-10205091-B4 | A method for predicting expression efficiency in cell-free expression systems | Inactive | 07-Feb-2002 | ||
| DE-10205091-A1 | Methods for predicting expression efficiency in cell-free expression systems | Active | 07-Feb-2002 | ||
| AU-2003210226-A1 | Method for predicting the expression efficiency in cell-free expression systems | Inactive | 07-Feb-2002 | ||
| US-20060024679-A1 | Method for predicting the expression efficiency in cell-free expression systems | Inactive | 07-Feb-2002 | C12P21/02 |
Labvantage - Biomax Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Labvantage - Biomax Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Labvantage - Biomax Investments (1)
Labvantage - Biomax’s most recent deal was a Buyout/LBO with Viscovery Software. The deal was made on 09-Sep-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Viscovery Software | 09-Sep-2007 | Buyout/LBO | Business/Productivity Software |
Labvantage - Biomax Exits (1)
Labvantage - Biomax’s most recent exit was on 09-Sep-2007 from Viscovery Software. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Viscovery Software | 09-Sep-2007 | Completed |
|
Labvantage - Biomax FAQs
-
When was Labvantage - Biomax founded?
Labvantage - Biomax was founded in 1997.
-
Where is Labvantage - Biomax headquartered?
Labvantage - Biomax is headquartered in Planegg, Germany.
-
What is the size of Labvantage - Biomax?
Labvantage - Biomax has 33 total employees.
-
What industry is Labvantage - Biomax in?
Labvantage - Biomax’s primary industry is Other Healthcare Services.
-
Is Labvantage - Biomax a private or public company?
Labvantage - Biomax is a Private company.
-
What is Labvantage - Biomax’s current revenue?
The current revenue for Labvantage - Biomax is .
-
How much funding has Labvantage - Biomax raised over time?
Labvantage - Biomax has raised $3.43M.
-
Who are Labvantage - Biomax’s investors?
Alpine Equity Management, BayBG Bayerische Beteiligungsgesellschaft, Eos Partners, Horizon 2020, and Sobera Capital have invested in Labvantage - Biomax.
-
Who are Labvantage - Biomax’s competitors?
Genestack, Clinithink, Averbis, Quest Diagnostics, and Genuity Science are some of the 12 competitors of Labvantage - Biomax.
-
When was Labvantage - Biomax acquired?
Labvantage - Biomax was acquired on 11-Oct-2022.
-
Who acquired Labvantage - Biomax?
Labvantage - Biomax was acquired by LabVantage Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
